Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: Implications for the pathogenesis of autism with multiple developmental anomalies

International Journal of Developmental Neuroscience

Volumn 29, Issue 4, 2011, Pages 359-364

  Tashiro, Yasura ^a   Oyabu, Akiko ^a   Imura, Yoshio ^a   Uchida, Atsuko ^a   Narita, Naoko ^b   Narita, Masaaki ^a  

^a MIE UNIVERSITY   (Japan)

^b BUNKYO UNIVERSITY   (Japan)

Author keywords

Autism; Cranial nerve; Facial motor nerve; Rat embryo; Valproic acid; Whole mount immunostaining

Indexed keywords

VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTISM; CONTROLLED STUDY; CRANIAL NERVE; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; DISEASE MODEL; EMBRYO; FACIAL NERVE; GLOSSOPHARYNGEAL NERVE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE FIBER; NERVE GROWTH; NONHUMAN; OCULOMOTOR NERVE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SOMITE; TRIGEMINAL NERVE; VAGUS NERVE;

ABNORMALITIES, MULTIPLE; ANIMALS; ANTICONVULSANTS; AUTISTIC DISORDER; CRANIAL NERVES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MATERNAL EXPOSURE; PERIPHERAL NERVES; PREGNANCY; RATS; RATS, WISTAR; VALPROIC ACID;

ANIMALIA; RATTUS;

EID: 79955758367     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.03.008     Document Type: Article

References (33)

1. Altman J., Bayer S.A. Development of the cranial nerve ganglia and related nuclei in the rat. Adv. Anat. Embryol. Cell Biol. 1982, 74:1-90.
2. Altmann C.R., Brivanlou A.H. Neural patterning in the vertebrate embryo. Int. Rev. Cytol. 2001, 203:447-482.
3. Chan R.K., Sawchenko P.E. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry. J. Neurosci. 1998, 18:371-387.
4. Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema. Br. J. Dermatol. 2000, 142:931-936.
5. Chen P.S., Wang C.C., Bortner C.D., Peng G.S., Wu X., Pang H., Lu R.B., Gean P.W., Chuang D.M., Hong J.S. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 2007, 149:203-212.
6. Conlon R.A., Rossant J. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development 1992, 116:357-368.
7. Dampney R.A. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 1994, 74:323-364.
8. Easter S.S., Ross L.S., Frankfurter A. Initial tract formation in the mouse brain. J. Neurosci. 1993, 13:285-299.
9. Ehlers K., Sturje H., Merker H.J., Nau H. Valproic acid-induced spina bifida: a mouse model. Teratology 1992, 45:145-154.
10. Erzurumlu R.S., Murakami Y., Rijli F.M. Mapping the face in the somatosensory brainstem. Nat. Rev. Neurosci. 2010, 11:252-263.
11. Filipek P.A., Accardo P.J., Baranek G.T., Cook E.H., Dawson G., Gordon B., Gravel J.S., Johnson C.P., Kallen R.J., Levy S.E., Minshew N.J., Ozonoff S., Prizant B.M., Rapin I., Rogers S.J., Stone W.L., Teplin S., Tuchman R.F., Volkmar F.R. The screening and diagnosis of autistic spectrum disorders. J. Autism Dev. Disord. 1999, 29:439-484.
12. Gillberg C., Winnergard I. Childhood psychosis in a case of Moebius syndrome. Neuropediatrics 1984, 15:147-149.
13. Gofflot F., van Maele-Fabry G., Picard J.J. Cranial nerves and ganglia are altered after in vitro treatment of mouse embryos with valproic acid (VPA) and 4-en-VPA. Brain Res. Dev. Brain Res. 1996, 93:62-69.
14. Ingram J.L., Peckham S.M., Tisdale B., Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 2000, 22:319-324.
15. Langston A.W., Gudas L.J. Identification of a retinoic acid responsive enhancer 3' of the murine homeobox gene Hox-1.6. Mech. Dev. 1992, 38:217-227.
16. Lee Y.M., Osumi-Yamashita N., Ninomiya Y., Moon C.K., Eriksson U., Eto K. Retinoic acid stage-dependently alters the migration pattern and identity of hindbrain neural crest cells. Development 1995, 121:825-837.
17. Matsubara Y., Mikami T. Teratogenic Potentially of Single Dose of Thalidomide in JW-NIBS Rabbits Jikken Dobutsu 1985, vol. 34:295-302.
18. Miller M.T., Stromland K., Ventura L., Johansson M., Bandim J.M., Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int. J. Dev. Neurosci. 2005, 23:201-219.
19. Miyazaki K., Narita N., Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int. J. Dev. Neurosci. 2005, 23:287-297.
20. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 2002, 52:576-579.
21. Narita M., Oyabu A., Imura Y., Kamada N., Yokoyama T., Tano K., Uchida A., Narita N. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat. Neurosci. Res. 2010, 66:2-6.
22. Nau H., Zierer R., Spielmann H., Neubert D., Gansau C. A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci. 1981, 29:2803-2814.
23. Noden D.M. Spatial integration among cells forming the cranial peripheral nervous system. J. Neurobiol. 1993, 24:248-261.
24. Ornitz E.M., Guthrie D., Farley A.H. The early development of autistic children. J. Autism Child. Schizophr. 1977, 7:207-229.
25. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?. Reprod. Toxicol. 2009, 28:1-10.
26. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001, 276:36734-36741.
27. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 1996, 370:247-261.
28. Rodier P.M., Bryson S.E., Welch J.P. Minor malformations and physical measurements in autism: data from Nova Scotia. Teratology 1997, 55:319-325.
29. Stromland K., Nordin V., Miller M., Akerstrom B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 1994, 36:351-356.
30. Tang D., Goldberg D.J. Bundling of microtubules in the growth cone induced by laminin. Mol. Cell. Neurosci. 2000, 15:303-313.
31. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child Neurol. 2001, 43:202-206.
32. Yamada T. Caudalization by the amphibian organizer: brachyury, convergent extension and retinoic acid. Development 1994, 120:3051-3062.
33. Yamamoto M., Schwarting G. The formation of axonal pathways in developing cranial nerves. Neurosci. Res. 1991, 11:229-260.